US2011236963A1PendingUtilityA1
System and method for analyte measurement
Est. expiryDec 22, 2017(expired)· nominal 20-yr term from priority
Y10T436/112499Y10T436/11Y10T436/12Y10T436/115831Y10T436/143333Y10T436/142222Y10T436/203332Y10T436/144444G01N 27/3274
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of measuring an analyte in a biological fluid comprises applying an excitation signal having a DC component and an AC component. The AC and DC responses are measured; a corrected DC response is determined using the AC response; and a concentration of the analyte is determined based upon the corrected DC response. Other methods and devices are disclosed.
Claims
exact text as granted — not AI-modified1 . An apparatus for determining the concentration of a medically significant component of a biological fluid, the apparatus comprising:
a cell for receiving a sample of the fluid, the cell supporting: a chemistry which reacts with the medically significant component; and first and second terminals across which the reaction of the chemistry with the medically significant component can be assessed; an instrument having: first and second terminals complementary to the first and second terminals, respectively, of the cell; wherein placement of the first and second terminals of the cell in contact with the first and second terminals, respectively, of the instrument permits the instrument to assess the reaction; and an assessment controller for: applying across the first and second terminals of the instrument a first signal; determining a first correction value in response of the cell to the first signal; assessing the reaction of the medically significant component with the chemistry; and combining the correction value with the result of the reaction assessment to produce an indication of the concentration of the medically significant component of the sample.
2 . The apparatus of claim 1 , wherein the first signal comprises a signal having an AC component.
3 . The apparatus of claim 2 , wherein the first signal comprises an AC signal.
4 . The apparatus of claim 1 , wherein the biological fluid comprises blood.
5 . The apparatus of claim 4 , wherein the medically significant component comprises glucose.
6 . The apparatus of claim 5 , wherein the first correction value comprises an indicated glucose-to-actual glucose correction factor.
7 . The apparatus of claim 1 , wherein the determining a first correction value step comprises:
determining a frequency response of the cell to the first signal; comparing the frequency response of the cell to a stored frequency response characteristic of a specific interferent to determine an interferent concentration; and determining the first correction value based upon the interferent concentration.
8 . The apparatus of claim 7 , wherein the first signal comprises a signal having an AC component.
9 . The apparatus of claim 8 , wherein the first signal comprises an AC signal.
10 . The apparatus of claim 7 , wherein the biological fluid comprises blood.
11 . The apparatus of claim 10 , wherein the medically significant component comprises glucose.
12 . The apparatus of claim 11 , wherein the interferent comprises hematocrit.
13 . The apparatus of claim 7 , wherein the first correction value comprises an indicated glucose-to-actual glucose correction factor.Join the waitlist — get patent alerts
Track US2011236963A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.